<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AE0047 [4-(4-benzhydrylpiperazino)phenethyl <z:chebi fb="36" ids="29309">methyl</z:chebi> 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-<z:chebi fb="1" ids="16227">pyridine</z:chebi> <z:chebi fb="0" ids="28965">dicarboxylate</z:chebi> dihydrochloride] is a new <z:chebi fb="0" ids="50075">dihydropyridine</z:chebi> calcium <z:chebi fb="68" ids="48706">antagonist</z:chebi> with protective effects against <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> and the occurrence of <z:hpo ids='HP_0001297'>stroke</z:hpo> in several animal models </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the effects of AE0047 on focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in <z:hpo ids='HP_0001297'>stroke</z:hpo>-prone spontaneously hypertensive rats </plain></SENT>
<SENT sid="2" pm="."><plain>AE0047 at a dose causing 20 or 40% systemic <z:hpo ids='HP_0002615'>hypotension</z:hpo> (1 or 3 mg kg-1) was given orally twice, 15 min and 24 h after occlusion </plain></SENT>
<SENT sid="3" pm="."><plain>The neurological status of animals was investigated 2, 24 and 48 h after occlusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> area of brain was measured 48 h after occlusion </plain></SENT>
<SENT sid="5" pm="."><plain>Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> resulted in the progressive deterioration of neurological status and large infarction in middle cerebral artery territories with 40% mortality </plain></SENT>
<SENT sid="6" pm="."><plain>AE0047 dose-dependently attenuated the deterioration of neurological status, and reduced mortality to 0 or 10% </plain></SENT>
<SENT sid="7" pm="."><plain>AE0047 significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size and left/right hemispheric area ratio, an index of <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>These results suggest that AE0047 has the ability to ameliorate ischaemic cerebral <z:hpo ids='HP_0001297'>stroke</z:hpo> in hypertensive patients </plain></SENT>
</text></document>